scholarly journals Symptomatic Childhood Uremic Pericardial Effusion: An Echocardiography Image

2020 ◽  
Vol 2 (2) ◽  
pp. 01-02
Author(s):  
Aamir Jalal Al-Mosawi

Large childhood symptomatic pericardial effusion demanding pericardio-centesis and pericardial drainage is rare and symptomatic childhood uremic pericardial effusion is even rarer. The aim of this paper is to report the rare occurrence of childhood uremic symptomatic pericardial effusion. A seven year old boy with the most extreme form of end-stage renal disease (anuric with no renal function). The patient developed large childhood symptomatic pericardial effusion which was diagnosed by echocardiography.

2020 ◽  
pp. 1-3

Large childhood symptomatic pericardial effusion demanding pericardiocentesis and pericardial drainage is rare and symptomatic childhood uremic pericardial effusion is even rarer. The aim of this paper is to report the rare occurrence of childhood uremic symptomatic pericardial effusion. A seven-year-old boy with the most extreme form of end-stage renal disease (anuric with no renal function). The patient developed large childhood symptomatic pericardial effusion which was diagnosed by echocardiography.


2020 ◽  
Vol 2 (2) ◽  
pp. 01-02
Author(s):  
Aamir Al-Mosawi

Large childhood symptomatic pericardial effusion demanding pericardio-centesis and pericardial drainage is rare and symptomatic childhood uremic pericardial effusion is even rarer. The aim of this paper is to report the rare occurrence of childhood uremic symptomatic pericardial effusion. A seven year old boy with the most extreme form of end-stage renal disease (anuric with no renal function). The patient developed large childhood symptomatic pericardial effusion which was diagnosed by echocardiography.


1989 ◽  
Vol 12 (10) ◽  
pp. 618-625 ◽  
Author(s):  
D.J. Leehey ◽  
J.T. Daugirdas ◽  
S. Popli ◽  
V.C. Gandhi ◽  
R. Pifarré ◽  
...  

The best approach to treatment of pericarditis accompanied by substantial pericardial effusion in end-stage renal disease (ESRD) patients is unknown. In a review of our experience, we found that ESRD patients with moderate-to-large or large (circa 250 mL or larger) pericardial effusions usually failed to improve with intensive dialysis and ultimately required surgical drainage of the effusion. Multivariate analysis revealed that effusion size was by far the most important factor predicting need for surgery. Since early pericardial drainage obviates the risk of sudden tamponade, we recommend that surgery without prior intensive dialysis therapy be considered in such patients.


2018 ◽  
Vol 7 (1) ◽  
pp. 33
Author(s):  
R Ram ◽  
BSangeetha Lakshmi ◽  
D Neeharika ◽  
CV Anil Kumar ◽  
MHarikrishna Reddy ◽  
...  

1985 ◽  
Vol 5 (1) ◽  
pp. 33-35 ◽  
Author(s):  
Karel Matousovic ◽  
Josef Moravek Stefan ◽  
Vitko Vladimir Prat ◽  
Milena Horcickova

We investigated the pharmacokinetics of non-metabolized cefotaxime in 10 patients undergoing CAPD. The elimination half-life after IV administration of I g cefotaxime was 3.1 ± 1.3 hr, i.e. two to three times longer than in individuals with normal renal function but similar to patients with severe renal insufficiency. An average of 2.18% of the dose was recovered in the effluent. The halflife of I g cefotaxime administered in the dialysis solutions was 1.4 ± 0.8 hr. This difference between the half-lives after intraperitoneal and intravenous administration indicates a faster transport through the peritoneal membrane. Intraperitoneally administered cefotaxime -250 mg four times daily, was effective in the treatment of peritonitis in three CAPD patients. Since its introduction in 1976, CAPD has become an effective therapy for end-stage renal disease. The most serious complication is peritonitis and effective treatment is essential. Cefotaxime, a new broad-spectrurn cephalosporin, is active against most gramnegative and gram-positive organisms. It possesses no nephrotoxicity and may be useful in the treatment of peritonitis and other infections in patients on CAPD. This study was done to evaluate the pharmacokinetics of cefotaxime administered intravenously and intraperitoneally during CAPD.


Sign in / Sign up

Export Citation Format

Share Document